...
首页> 外文期刊>Cancer Cell International >Upregulated expression of DIXDC1 in intestinal-type gastric carcinoma: co-localization with β-catenin and correlation with poor prognosis
【24h】

Upregulated expression of DIXDC1 in intestinal-type gastric carcinoma: co-localization with β-catenin and correlation with poor prognosis

机译:DIXDC1在肠型胃癌中的表达上调:与β-catenin的共定位及其与不良预后的关系

获取原文
           

摘要

DIXDC1 (Dishevelled-Axin domain containing 1) is a positive regulator of the Wnt pathway. In the field of cancer research, the role of DIXDC1 is unclear. Our previous in vitro study showed that DIXDC1 enhances β-catenin nuclear accumulation in gastric cancer cell lines. The aim of this study was to detect the expression of DIXDC1 in different histological subtypes of gastric carcinoma and to evaluate the correlation between the expression of DIXDC1 and β-catenin localization and clinicopathological parameters, including patients’ survival. Immunohistochemical staining was performed to characterize the expression of DIXDC1 and β-catenin in archived materials from 259 cases of gastric carcinoma. The χ2 test and the Fisher’s test were used to analyze correlations between DIXDC1 expression, β-catenin localization, and clinicopathological parameters. Univariate analyses were performed using the Kaplan–Meier method, and the survival difference between groups was assessed by the log-rank test. Multivariate analysis was performed using the Cox proportional hazards regression model. Positive DIXDC1 staining was detected in tumor cells in 123 of 259 (47.5 %) cases. DIXDC1 expression in gastric carcinoma was significantly correlated with the histological intestinal-type (P  0.001), the depth of tumor invasion (P  0.001) and the lymph node metastasis (P = 0.006). In the intestinal-type, DIXDC1 was correlated with the nuclear and cytoplasmic β-catenin expression (P = 0.002). Kaplan–Meier analysis indicated that patients with high DIXDC1 expression had poor disease-specific survival (P  0.001), especially in the intestinal-type. Moreover, multivariate regression analysis showed that positive expression of DIXDC1 was an independent prognostic predictor of intestinal-type gastric carcinoma. Our study indicated that DIXDC1 is a significant independent prognostic indicator in intestinal-type gastric carcinoma that plays an important role in carcinogenesis and progression of gastric carcinoma through the Wnt signaling pathway.
机译:DIXDC1(包含1的Dishevelled-Axin域)是Wnt途径的正调节剂。在癌症研究领域,DIXDC1的作用尚不清楚。我们先前的体外研究表明DIXDC1增强了胃癌细胞系中β-catenin的核积累。这项研究的目的是检测DIXDC1在胃癌的不同组织学亚型中的表达,并评估DIXDC1的表达与β-catenin的定位与临床病理参数之间的相关性,包括患者的生存率。进行免疫组织化学染色以表征DIXDC1和β-catenin在259例胃癌的存档资料中的表达。 χ2检验和Fisher检验用于分析DIXDC1表达,β-catenin定位和临床病理参数之间的相关性。使用Kaplan-Meier方法进行单变量分析,并通过对数秩检验评估组之间的生存差异。使用Cox比例风险回归模型进行多变量分析。在259例(47.5%)病例中,有123例在肿瘤细胞中检测到DIXDC1阳性染色。胃癌中DIXDC1的表达与组织学肠型(P <0.001),肿瘤浸润深度(P <0.001)和淋巴结转移(P = 0.006)显着相关。在肠型中,DIXDC1与核和细胞质β-catenin表达相关(P = 0.002)。 Kaplan-Meier分析表明,DIXDC1高表达的患者特定疾病的生存率较差(P <0.001),特别是在肠道类型中。此外,多因素回归分析显示DIXDC1的阳性表达是肠型胃癌的独立预后指标。我们的研究表明,DIXDC1是肠型胃癌的重要独立预后指标,在通过Wnt信号通路在胃癌的发生和发展中起着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号